MENU
AAPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ascentage Pharma Group (AAPG) Ownership - Who owns Ascentage Pharma Group?

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.73B
P/E Ratio
N/A
Total Cash
1.66B
Projected Growth
N/A
Total Debt
1.72B
Revenue
390.6M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
17.80
Total Debt/Equity
N/A
Revenue/Share
0.95 USD as % of share price
View a ticker or compare two or three
AAPG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details